4.6 Article

Female Urinary Incontinence and Artificial Urinary Sphincter: Study of Efficacy and Risk Factors for Failure and Complications

Journal

EUROPEAN UROLOGY
Volume 59, Issue 6, Pages 1048-1053

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.eururo.2011.03.006

Keywords

Intrinsic sphincter deficiency; Urinary incontinence; Artificial urinary sphincter; Women; Risk factors

Ask authors/readers for more resources

Background: The artificial urinary sphincter (AUS) has become a commonly used therapy for severeurinary incontinence (UI) due to intrinsic sphincter deficiency (ISD). Objective: To evaluate retrospectively the efficacy and risk factors for failure and complications of AUS implantation in women with nonneurologic UI. Design, setting, and participants: From May 1987 to December 2009, 215 women with ISD were treated by AUS implantation, with a mean age of 62.8 yr and a mean follow-up of 6 yr (standard deviation: 5.6 yr). Previous surgical procedures to treat incontinence had been performed in 88.8% of the patients. Urodynamic assessment was required. Patients using only 0 or 1 pad at the end of follow-up were considered continent. The patient's level of satisfaction was evaluated by a global analogue scale and clinical interview. Intervention: All women had AUS implantation. Measurements: Patients were evaluated for continence rate, risk factors for failures, and complications. Results and limitations: At the end of follow-up, 158 patients (73.5%) were continent, and 170 (79%) were satisfied. The redo rate was 15.3% after a mean interval of 8.47 yr for the first redo procedure. Fifteen explantations (7%) were performed. The only risk factor for intraoperative complications (10.7%) was smoking (p < 0.004). Six patients (2.8%) were lost to follow-up. AUS failed to treat incontinence in 51 patients (23.7%) due to defective manipulation in 27.4% of the cases. On multivariate analysis, risk factors for failure were age > 70 yr (odds ratio [OR]: 2.46), a history of the Burch procedure (OR: 2.28), or pelvic radiotherapy (OR: 4.37) (p < 0.05). Conclusions: The place for this safe and long-lasting effective technique in the treatment of UI due to recurrent sphincter deficiency is confirmed. Screening for these risk factors should allow better patient selection. (C) 2011 European Association of Urology. Published by Elsevier B. V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available